XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating Expenses:    
Research and development $ 10,786 $ 10,553
General and administrative 2,989 3,549
Total operating expenses 13,775 14,102
Loss from operations (13,775) (14,102)
Other income (expense):    
Grant income 5,086 4,912
Other income, net 214 244
Interest expense (5) (10)
Loss on currency translation from liquidation of subsidiary   (195)
Total other income, net 5,295 4,951
Net loss (8,480) (9,151)
Foreign currency translation adjustment, including reclassifications   195
Total comprehensive loss $ (8,480) $ (8,956)
Net loss per share, basic (in dollars per share) $ (0.14) $ (0.27)
Net loss per share, diluted (in dollars per share) $ (0.14) $ (0.27)
Weighted-average common shares outstanding, basic (in shares) 61,828,149 33,735,269
Weighted-average common shares outstanding, diluted (in shares) 61,828,149 33,735,269